Le Lézard
Classified in: Science and technology
Subject: PDT

Clarivate Launches Research Horizon Navigator to Pinpoint Future Breakthrough Areas


Insights from the new InCites Benchmarking & Analytics module support strategic investment and demonstrate impact

LONDON, June 4, 2024 /CNW/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today launched Research Horizon Navigatortm, a powerful new AI-native module within InCites Benchmarking & Analyticstm that highlights emerging research topics where future breakthroughs are likely to occur. Academics, funding agencies, government research organizations and research strategists will be able to identify new research trends and determine the most impactful areas for future investments and strategies.

Research Horizon Navigator draws on trusted data from the Web of Science Core Collectiontm and uses a novel methodology developed by the Institute for Scientific Information (ISI)tm to identify new topics emerging in articles, reviews and conference proceedings published in the past five years, as well as a new indicator which measures the interdisciplinarity of each emerging topic. Within Research Horizon Navigator, each topic is labeled with a research theme assigned by generative AI. Each topic also offers an interactive visualization showing how papers are connected and includes an overview where users can explore which authors and institutions have contributed. 

Emmanuel Thiveaud, Senior Vice President, Research and Analytics, Academia & Government at Clarivate said: "By empowering institutions to understand where research is heading and who is leading the way, we hope to accelerate breakthroughs across disciplines and countries. With Research Horizon Navigator we continue to provide intelligence you can trust to transform the world for the better."

Research Horizon Navigator is available now to all InCites Benchmarking & Analytics subscribers, providing an invaluable resource to inform horizon-scanning projects and strategic planning initiatives. Key applications for the tool include:

Feedback from the research community will inform further enhancements to Research Horizon Navigator within InCites. Emerging topics will also be incorporated into Web of Science Research Intelligence, so institutions can identify relevant funding opportunities within emerging research areas and gain insight into where they are strategically positioned to succeed. 

About Clarivate
Clarivatetm is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit www.clarivate.com

Media contact:
Rebecca Krahenbuhl, Senior Manager, External Communications, Academia & Government
[email protected]

SOURCE Clarivate Plc


These press releases may also interest you

at 21:09
On June 29, the "Gather Great Wisdom to Shape the Future of Intelligent Manufacturing?Special Exhibition on Design Intelligence and High Quality Development", hosted by the China Academy of Art (CAA), opened at the National Museum of China in...

at 20:55
Intermap Technologies ("Intermap" or the "Company"), a global leader in 3D geospatial products and intelligence solutions, announces a new financing. The Company is offering up to a maximum of 4,300,000 Class "A" common shares of the Company...

at 20:45
"The Classic Quotes by Xi Jinping," a multilingual TV show produced by China Media Group, aired in Kazakhstan on Tuesday after Chinese...

at 20:07
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...

at 20:05
Enterprises in Asia Pacific are moving toward software-defined networking (SDN) to make communication more secure and resilient and speed up business decision-making, according to a new research report published today by Information Services Group...

at 20:00
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal...



News published on and distributed by: